ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum (Q45875096)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2011

Language	Label	Description	Also known as
English	ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum	scientific article published in December 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Plasmodium falciparum

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shan Zong

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Matthias W Kron

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Christian Epp

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Tatjana Engler

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Hermann Bujard

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Stefan Kochanek

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Florian Kreppel

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Journal of Gene Medicine

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

13

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

12

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

670-679

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Interactions between merozoite surface proteins 1, 6, and 7 of the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Band 3 is a host receptor binding merozoite surface protein 1 during thePlasmodium falciparuminvasion of erythrocytes

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Expression and purification of Plasmodium falciparum MSP-1(42): A malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

The merozoite surface protein 1 complex of human malaria parasite Plasmodium falciparum: interactions and arrangements of subunits

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Effective induction of high-titer antibodies by viral vector vaccines

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Improved system for helper-dependent adenoviral vector production

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

A composite CMV-IE enhancer/beta-actin promoter is ubiquitously expressed in mouse cutaneous epithelium

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.1627

21 January 2018

Identifiers

10.1002/JGM.1627

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22095915

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45875096&oldid=2088243731"